Pulmonary hypertension and congenital heart disease: the clinic beyond the evidence
Anno:
2024
Eisenmenger syndrome (ES),first described by Victor Eisenmenger, was defined by Paul Wood in pathophysiologic terms as “pulmonary hypertension (PH) at systemic level, caused by a high pulmonary vascular resistance (PVR), with reversed or bidirectional shunt at aorto-pulmonary, ventricular, or atrial level.” It represents the most severe hemodynamic phenotype of…